150 related articles for article (PubMed ID: 22634606)
1. The WAP protein Trappin-2/Elafin: a handyman in the regulation of inflammatory and immune responses.
Verrier T; Solhonne B; Sallenave JM; Garcia-Verdugo I
Int J Biochem Cell Biol; 2012 Aug; 44(8):1377-80. PubMed ID: 22634606
[TBL] [Abstract][Full Text] [Related]
2. Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin.
Marischen L; Wesch D; Schröder JM; Wiedow O; Kabelitz D
Scand J Immunol; 2009 Dec; 70(6):547-52. PubMed ID: 19906197
[TBL] [Abstract][Full Text] [Related]
3. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.
Baranger K; Zani ML; Chandenier J; Dallet-Choisy S; Moreau T
FEBS J; 2008 May; 275(9):2008-20. PubMed ID: 18341586
[TBL] [Abstract][Full Text] [Related]
4. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.
Ghosh M; Shen Z; Fahey JV; Cu-Uvin S; Mayer K; Wira CR
Immunology; 2010 Feb; 129(2):207-19. PubMed ID: 19824918
[TBL] [Abstract][Full Text] [Related]
5. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.
Sallenave JM
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631
[TBL] [Abstract][Full Text] [Related]
6. WAP domain proteins as modulators of mucosal immunity.
Wilkinson TS; Roghanian A; Simpson AJ; Sallenave JM
Biochem Soc Trans; 2011 Oct; 39(5):1409-15. PubMed ID: 21936824
[TBL] [Abstract][Full Text] [Related]
7. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.
Drannik AG; Henrick BM; Rosenthal KL
Biochem Soc Trans; 2011 Oct; 39(5):1427-32. PubMed ID: 21936827
[TBL] [Abstract][Full Text] [Related]
8. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases.
Tanga A; Saidi A; Jourdan ML; Dallet-Choisy S; Zani ML; Moreau T
Biochem Pharmacol; 2012 Jun; 83(12):1663-73. PubMed ID: 22465040
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
10. Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C.
Drannik AG; Nag K; Yao XD; Henrick BM; Sallenave JM; Rosenthal KL
PLoS One; 2012; 7(4):e35866. PubMed ID: 22545145
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
12. Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.
Bellemare A; Vernoux N; Morin S; Gagné SM; Bourbonnais Y
BMC Microbiol; 2010 Oct; 10():253. PubMed ID: 20932308
[TBL] [Abstract][Full Text] [Related]
13. Elafin and its precursor trappin-2: What is their therapeutic potential for intestinal diseases?
Deraison C; Bonnart C; Langella P; Roget K; Vergnolle N
Br J Pharmacol; 2023 Jan; 180(2):144-160. PubMed ID: 36355635
[TBL] [Abstract][Full Text] [Related]
14. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
15. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
16. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis.
Motta JP; Bermúdez-Humarán LG; Deraison C; Martin L; Rolland C; Rousset P; Boue J; Dietrich G; Chapman K; Kharrat P; Vinel JP; Alric L; Mas E; Sallenave JM; Langella P; Vergnolle N
Sci Transl Med; 2012 Oct; 4(158):158ra144. PubMed ID: 23115353
[TBL] [Abstract][Full Text] [Related]
17. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
19. Trappin ovine molecule (TOM), the ovine ortholog of elafin, is an acute phase reactant in the lung.
Brown TI; Mistry R; Collie DD; Tate S; Sallenave JM
Physiol Genomics; 2004 Sep; 19(1):11-21. PubMed ID: 15292488
[TBL] [Abstract][Full Text] [Related]
20.
Villeret B; Solhonne B; Straube M; Lemaire F; Cazes A; Garcia-Verdugo I; Sallenave JM
Front Immunol; 2020; 11():117. PubMed ID: 32117268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
